Close
Nordic 9Nordic 9

Sound Bioventures (investor - Venture Capital)

Sweden soundbioventures.com
See something wrong or missing? Let us know
Offices:Malmö

Sound Bioventures is a venture capital fund from Sweden investing in about-to-be clinical or clinical stage private companies in Europe and USA developing therapies in specialty therapeutics areas

Average round investment:26.1M USD
Average number per year:2.8
Distribution: 2025 (3)2024 (3)2023 (4)2022 (1)
Portfolio companies: Denmark Boost PharmaSweden IflaiSpain Arthex Biotech S.L. See the entire list
Mostly invests in: Denmark Denmark (4) Health services (11)
See the entire list

Showing 3 of 11 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Sound Bioventures mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Sound Bioventures

Name Criteria
France C4Ventures
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, France
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
Finland EVLI Growth Partners
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: Sweden, United Kingdom, Netherlands
  • Average number of deals per year: 2.9
  • Active last 12 months: Yes
United States Menlo Ventures
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, AI (big data), Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: Denmark, Sweden, United Kingdom
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
France AG2R LA MONDIALE
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: France
  • Average number of deals per year: 2.9
  • Active last 12 months: Yes
France blisce/
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, AI (big data), Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: Denmark, Sweden, United Kingdom, France
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
France Mirova
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, AI (big data), Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: Spain, France, Netherlands
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Switzerland Novartis Venture Fund
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: Spain, United Kingdom, Netherlands
  • Average number of deals per year: 2.9
  • Active last 12 months: Yes
United Kingdom Expedition Growth Capital
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, AI (big data), Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: Denmark, Sweden, United Kingdom, France, Netherlands
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Norway Hadean Ventures
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing, AI (big data), Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: Denmark, Sweden, Spain, France, Netherlands
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
France Turenne Capital Partenaires
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: France
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Top